Skip to content

Discontinued — last reported Q3 '16

Gross Profit at other companies

Amgen logo
AmgenAMGN
$5.87B+13.4%
ANI Pharmaceuticals logo
ANI PharmaceuticalsANIP
$143.88M+16.0%
Vir Biotechnology, Inc. logo
Vir Biotechnology, Inc.VIR
$1.2M-60.2%
Nektar Therapeutics logo
Nektar TherapeuticsNKTR
$21.81M+2.9%
TG Therapeutics logo
TG TherapeuticsTGTX
BridgeBio Pharma logo
BridgeBio PharmaBBIO

Other financials

Income statement

See full
Revenue$141.0K+95.8%
Operating income-$116.2M-23.8%
Net income-$104.9M-20.7%
EPS (diluted)-$1.15-5.5%

Balance sheet

See full
Cash & equivalents$176.3M+51.7%
Total debt$36.8M+59.4%
Total equity$636.0M+5.2%
Total assets$789.0M+19.4%

Cash flow

See full
Operating cash flow-$119.7M-29.1%
CapEx$23.0K-73.3%
Free cash flow-$119.7M-29.0%

Valuation

See full
Market cap$1.91B+82.0%
Enterprise value$1.77B+85.0%
P/S26.9×-3,445×

Profitability

See full
Gross margin36.3%
Operating margin-543.9%-271pp
Net margin-508.5%-254pp
FCF margin-428.4%-214pp

Returns & leverage

See full
Return on equity-58.1%+7.9pp
Debt / equity0.1×0.0×
Current ratio15.1×-4.3×

Where this comes from

Calculated from Viridian Therapeutics, Inc.’s reported figures.

The official record: Viridian Therapeutics, Inc.’s 10-K, filed March 15, 2018, on SEC EDGAR. View the filing →

Questions, answered.

What does gross profit mean?
Revenue minus cost of revenue — the profit available to cover operating expenses, representing the company's pricing power and production efficiency.